8-K 1 r8k-003.txt FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 15, 2003 Access Pharmaceuticals, Inc. ------------------------------------------------------ (Exact name of registrant as specified in its charter) Delaware 0-9314 83-0221517 ------------------------ ------------------------ ------------------- (State of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 2600 Stemmons Freeway, Suite 176, Dallas, Texas 75207 ----------------------------------------------- --------- (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (214) 905-5100 -------------- Not applicable ------------------------------------------------------------- (Former name or former address; if changed since last report) Item 5. Other Events. The registrant hereby incorporates by reference the press release dated March 31, 2003 attached hereto as Exhibit 99.1 ("Access Pharmaceuticals, Inc. Announces First Quarter Financial Results") Item 7. Financial Statements, Pro Forma Financial Information and Exhibits (c) Exhibits Exhibit Number Description ------- ------------ 99.1 Press Release dated May 15, 2003 - "Access Pharmaceuticals, Inc. Announces First Quarter Financial Results" 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Access Pharmaceuticals, Inc. (Registrant) By: /s/ Kerry P. Gray ------------------ Kerry P. Gray President and CEO Dated May 16, 2003 3 EXHIBIT INDEX Exhibit Number Description ------- ------------ 99.1 "Access Pharmaceuticals, Inc. Announces First Quarter Financial Results" 4